A trial search identifies studies to examine. The study team must separately check the relevant site, cohort and full eligibility requirements.
NCI describes finding a study, discussing it with the team, informed consent and formal screening as distinct steps. A registry identifier helps distinguish studies, while the dated protocol and record describe the design and entry rules. Overall recruiting status can reflect an open facility elsewhere; it does not establish an available place in the relevant local cohort. A matching diagnosis or biomarker is only part of eligibility. Medical-history review and required tests can still exclude participation after an initial discussion.
Shares Investigational New Drug application, Expanded access (compassionate use), Trial protocol and statistical analysis plan, Clinical trial.
Shares Right to Try Act 2018 and state right-to-try laws, Expanded access (compassionate use), Clinical trial.
Shares Accrual and enrolment, Trial registration and results reporting (ClinicalTrials.gov, EU CTR), Trial protocol and statistical analysis plan, Clinical trial.
Shares Trial registration and results reporting (ClinicalTrials.gov, EU CTR), Trial protocol and statistical analysis plan.
Shares Right to Try Act 2018 and state right-to-try laws, Expanded access (compassionate use).
Shares Accrual and enrolment, Trial registration and results reporting (ClinicalTrials.gov, EU CTR), Trial protocol and statistical analysis plan, Clinical trial.
Shares Investigational New Drug application, Right to Try Act 2018 and state right-to-try laws, Expanded access (compassionate use).
Shares Trial registration and results reporting (ClinicalTrials.gov, EU CTR), Trial protocol and statistical analysis plan.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/